More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study

Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.

from Health and Science https://ift.tt/KcoeIzX
https://ift.tt/kfIrZT4
https://ift.tt/qtLjmAk